Speaking from the agency's perspective, let me say that we don't have a contingency fund. I'm quite jealous. It would be nice to have that sort of fund.
We are looking. It's a hard question to answer, because we don't know what the future holds in the next little while. Right now our focus is on research and diagnostics at the laboratory and how we can assist with the potential vaccine. We're reallocating resources to take care of that need right now. But I think the question is best answered by a number of different departments: CIHR, who are doing some work involving research funding; and some of the aid agencies, in terms of how much we contribute to the WHO and how much we help other countries in the world. We're working on that exactly.
Currently, from a diagnostic perspective I think the agency is well resourced, but determining how best to deal with this organism really depends upon what the Government of Canada wants to do on the global scene.